STOCKHOLDERS’ EQUITY |
3 Months Ended |
|---|---|
Mar. 31, 2022 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY |
4. STOCKHOLDERS’ EQUITY
COMMON STOCK
During the three months ended March 31, 2022, the Company issued an aggregate of 16,811 shares of common stock pursuant to exercises of warrants to purchase an aggregate of 16,811 shares of common stock for aggregate net proceeds of $69.
During the three months ended March 31, 2022, the Company issued an aggregate of 144,497 shares of common stock for services to employees and consultants with an aggregate issuance date fair value of $331.
STOCK-BASED COMPENSATION
The Company recognized stock-based compensation expense related to common stock, stock options and warrants for the three months ended March 31, 2022 and 2021 of $1,962 and $415, respectively, which is included within compensation expense on the condensed consolidated statements of operations. As of March 31, 2022, there was $5,692 of unrecognized stock-based compensation expense that will be recognized over the weighted average remaining vesting period of 1.84 years.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|